ryodipine has been researched along with Angor Pectoris in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Naumov, VG; Naumova, NA; Shkarin, VV | 1 |
Chuklin, SM; Kupnovyts'ka, IH | 1 |
Al'perovich, BR; Gneushev, ET; Kukes, VG; Nasyrov, MN; Rumiantsev, AS; Svetyĭ, LI; Taratuta, TV | 1 |
Gromnatskiĭ, NI; Vishnevskiĭ, VI | 1 |
Glukhovtsev, EV; Gratsianskiĭ, NA; Kocherga, EIu | 1 |
2 trial(s) available for ryodipine and Angor Pectoris
Article | Year |
---|---|
[The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
Topics: Angina Pectoris; Blood Pressure; Cardiovascular Agents; Echocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Prognosis; Respiratory Function Tests | 1993 |
[Anti-angina effect of foridon in patients with stable exertion-induced stenocardia].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Physical Exertion; Placebos; Research Design; Vasodilator Agents | 1988 |
3 other study(ies) available for ryodipine and Angor Pectoris
Article | Year |
---|---|
[The efficacy of foridon in treating stenocardia patients].
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Drug Evaluation; Drug Therapy, Combination; Humans; Immunity, Cellular; Middle Aged; Nifedipine; Nitrates; Vasodilator Agents | 1991 |
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Nifedipine; Propranolol | 1990 |
[Evaluation of the antianginal effects of foridon by transesophageal stimulation of the left atrium].
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, Artificial; Drug Evaluation; Female; Heart Atria; Humans; Male; Middle Aged; Nifedipine; Prognosis; Vasodilator Agents | 1990 |